| ²é¿´: 642 | »Ø¸´: 4 | |||
[½»Á÷]
ACS Nano£ºÀûÓñãЯʽÉ豸¶¨Á¿¼ì²â΢Á¿ÑªÒºÖÐÊ®¼¸ÖÖÉúÎï±êÖ¾Îï
|
|||
|
µ±ÎÀÉúÉèÊ©ÓÐÏÞµÄÆ«Ô¶µØÇø·¢ÉúÁ÷Ðв¡Ê±£¬ÄÇÀïµÄÈËÃÇÐèÒªÄܹ»ÔÚÒ½ÔºÍâµÄµØ·½Ê¹ÓõıãЯʽÕï¶ÏÉ豸¡£ÎªÁ˽â¾ö¶ÔÕâЩÉ豸²»¶ÏÔö¼ÓµÄÐèÇó£¬À´×ÔÈðÊ¿ÂåÉ£Áª°îÀí¹¤Ñ§Ôº£¨EPFL£©µÄÑо¿ÈËÔ±¿ª·¢³öÒ»Öֵͳɱ¾µÄ±ãЯʽ΢Á÷ÌåÕï¶ÏÉ豸¡£ËüÒѳɹ¦µØÔÚ°£²©À²¡¶¾£¨Ebola£©´«È¾²¡ÉϽøÐÐÃâÒß²âÊÔ£¬Ò²Äܹ»ÓÃÓÚ¼ì²âÐí¶àÆäËû¼²²¡¡£Ïà¹ØÑо¿½üÆÚ·¢±íÔÚACS NanoÆÚ¿¯ÉÏ£¬ÂÛÎıêÌâΪ¡°A Digital¨CAnalog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples¡±¡£ ÔÚ¹ýÈ¥µÄ¼¸Ä꣬΢Á÷ÌåÉ豸ÒÑÔÚÕï¶ÏÁìÓòÏÔʾ³ö·Ç·²µÄDZÁ¦¡£ËüÃÇÊÇÓɹèÏð½ºÖƳɵģ¬º¬ÓÐÍ··¢Ë¿¿í¶ÈµÄ΢СͨµÀ¡£Î¢Á÷ÌåÉ豸Äܹ»¿ìËٵؼì²â¼«ÉÙÁ¿ÑªÒºÖеÄÐí¶àÖÖ²»Í¬µÄÉúÎï±êÖ¾Îï¡£ ÔÚEPFL£¬ÓÉSebastian MaerklÁìµ¼µÄÉúÎïÍøÂçÌØÕ÷ʵÑéÊÒ£¨Laboratory of Biological Network Characterization, LBNC£©ÒÑ¿ª·¢³öÒ»ÖÖÐÂÐ͵Ä΢Á÷ÌåÆ½Ì¨¡£ËüÊÇÒ»ÖÖÍêÈ«×ÔÎÒά³ÖµÄÒÀ¿¿µç³ØÄÜÔ´ÔËÐеıãЯʽÉ豸¡£ËüÎÞ·ìµØÓëÁ®¼ÛµÄÏÔ΢¾µÒ»ÆðÔË×÷£¬´Ó¶øÌṩ·Ç³£¸ßˮƽµÄ¼ì²â׼ȷÐÔ¡£ÕâÖÖÆ½Ì¨Äܹ»ÔÚ΢Á¿ÑªÒº£¨Ð¡ÓÚ0.005΢Éý£©Öж¨Á¿¼ì²â¸ß´ï16ÖÖ²»Í¬µÄÉúÎï±êÖ¾Îï·Ö×Ó¡£ÕâЩÉúÎï±êÖ¾Îïͨ³£ÊÇø¡¢µ°°×¡¢¼¤ËØ»ò´úлÎËüÃÇÔÚѪҺÖеÄŨ¶È¿ÉÌṩ¹ØÓÚ²¡È˽¡¿µ×´¿öµÄ׼ȷÐÅÏ¢¡£ Ò»ÖÖ΢Á÷ÌåÆ½Ì¨¸ø³öÁ½ÖÖ¼ì²â¶Á³öÖµ ÕâÖÖ΢Á÷ÌåÉ豸ÊǶÀÌØµÄÔÒòÔÚÓÚËüÊÇÓÉÄ£ÄâÐźżì²â×°ÖúÍÊý×ÖÐźżì²â×°ÖÃÕâÁ½ÖÖ×°ÖÃ×é³ÉµÄ£¬¶øÆù½ñΪֹ£¬³£¹æµÄÉ豸ֻÕûºÏÆäÖеÄÒ»ÖÖ×°Öá£Í¼Æ·À´×ÔAlban Kakulya¡£ ÕâÖÖÉ豸ÊǶÀÌØµÄÔÒòÔÚÓÚËüÊÇÓÉÄ£ÄâÐźżì²â×°ÖúÍÊý×ÖÐźżì²â×°ÖÃÕâÁ½ÖÖ×°ÖÃ×é³ÉµÄ£¬¶øÆù½ñΪֹ£¬³£¹æµÄÉ豸ֻÕûºÏÆäÖеÄÒ»ÖÖ×°Öá£Êý×ÖÐźżì²âÊǸ߶ÈÁéÃôµÄ£¬Äܹ»¼ì²âµ¥¸öÉúÎï±ê¼ÇÎïµÄ´æÔÚ¡£µ«ÊÇ£¬µ±ÉúÎï±êÖ¾ÎïµÄŨ¶ÈÌ«¸ßʱ£¬ÓÉÓÚÐźű¥ºÍµÄÔÒò£¬Ëü±íÏÖÇ·¼Ñ¡£ÁíÒ»·½Ã棬ģÄâÐźżì²âÔڽϸߵÄÉúÎï±ê¼ÇÎïŨ¶Èʱ±íÏÖµÃ×îºÃ¡£Í¬Ê±Ê¹ÓÃÕâÁ½ÖÖ¼ì²â×°Ö㬾ÍÄܹ»ÔÚ¶Ìʱ¼äÄÚ³¹µ×µØ·ÖÎöÒ»µÎѪÖеijɷ֡£ÕâÖÖ·ÖÎöÌṩÕä¹óµÄÒ½ÁÆÐÅÏ¢£ºËü¿ÉÄÜÓÐÖúÒ½Éú×÷³öÔçÆÚÕï¶Ï»òÕßÈ·¶¨¼²²¡Ëù´¦µÄ½×¶Î¡£ ³õʼµÄ²âÊÔÒѳɹ¦µØÔÚº¬Óп¹°£²©À²¡¶¾¿¹ÌåµÄÑùÆ·ÖÐÖ´ÐУ¬ÆäÖп¹°£²©À²¡¶¾¿¹Ìåָʾ×ÅÔÚ³öÏÖÖ¢×´µÄºÍδ³öÏÖÖ¢×´µÄ²¡ÈËÌåÄÚ´æÔÚÕâÖÖ²¡¶¾¡£ÕâÖÖÉ豸¿ÉÄÜÄܹ»Ç±Ôڵؼì²â´óÁ¿µÄÆäËûµ°°×ÉúÎï±êÖ¾ÎïºÍ·Ö×Ó¡£ ѪҺÑùÆ·¿É±»Ö±½Ó×°ÔØµ½ÕâÖÖ΢Á÷ÌåÉ豸ÖУ¬¶øÇÒÔÚÎÞÐèÑùÆ·Ô¤´¦ÀíµÄÇé¿öϽøÐÐоƬÉϵÄÉúÎï±êÖ¾ÎﶨÁ¿¼ì²â¡£Í¼Æ·À´×ÔAlban Kakulya¡£ ÎÞÐèѪҺÑùÆ·¶ÔÔ¤´¦Àí »¹Óиü¶àµÄºÃÏûÏ¢¡£EPFLÑо¿ÈËÔ±·¢ÏÖËûÃÇÄܹ»Ö±½Ó½«ÑªÒºÑùÆ·×°ÔØµ½ÕâÖÖ΢Á÷ÌåÉ豸ÖУ¬¶øÇÒÔÚÎÞÐèÑùÆ·Ô¤´¦ÀíµÄÇé¿öϽøÐÐоƬÉϵÄÉúÎï±êÖ¾ÎﶨÁ¿¼ì²â¡£ÂÛÎĵÚÒ»×÷ÕßFrancesco Piraino˵£¬¡°¶ÔÑо¿ÈËÔ±À´Ëµ£¬Äܹ»±ÜÃâ·ÖÀëѪҺÊǷdz£ÁîÈ˸ÐÐËȤµÄ¡£¡±ÑªÒºÖеÄѪ½¬·ÖÀëÐèÒªÀëÐÄ»ú¡¢´óÁ¿µÄÑùÆ·ºÍ½Ï³¤µÄ´¦Àíʱ¼ä¡£ ÔÚ×ÊÔ´ÓÐÏÞµÄÇøÓò½øÐÐÕï¶Ï Piraino˵£¬¡°ÕâÖÖÆ½Ì¨½«ÒýÁìÈËÃÇ¿ª·¢ÐµIJâÊÔÀàÐÍÒÔ±ãÂú×ã²»¶ÏÔö¼ÓµÄ¶ÔÕï¶Ï²âÊÔµÄÐèÇó¡£¶ÔÔÚ×ÊÔ´ÓÐÏ޵ĵØÇø¹¤×÷µÄÒ½ÎñÈËÔ±¶øÑÔ£¬Ëü½«ÊǷdz£ÓÐÓõġ£¡±±ÈÈ磬ÕâÖÖÉ豸¿ÉÄܱ»ÓÃÓÚ¼à¿ØµØ·½²¡¡¢Á÷Ðв¡ºÍ´óÁ÷ÐÐÐÔ¼²²¡±¬·¢¡££¨ÉúÎï¹È £© doi:10.1021/acsnano.5b07939 A Digital¨CAnalog Microfluidic Platform for Patient-Centric Multiplexed Biomarker Diagnostics of Ultralow Volume Samples |
» ²ÂÄãϲ»¶
ÇëÎʽñÄê¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÉ걨£¬ÊÇ·ñ»¹ÐèÒª°Ñ´ú±íÐÔÂÛÎĺͻñ½±Ö¤Ã÷ÉÏ´«µ½¸½¼þÖУ¿
ÒѾÓÐ4È˻ظ´
ÇëÎÊInternational Journal of Biological Macromolecules Õâ¸öÆÚ¿¯ÔõôÑù£¿
ÒѾÓÐ16È˻ظ´
¿ÚÇ»Âò¢Ãæ¿ÆÑ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ289È˻ظ´
ÇëÎʽñÄê¹ú»ùÉ걨£¬²ÎÓëÈËÓÐÓʼþÈ·ÈÏ»·½ÚÂð£¿
ÒѾÓÐ3È˻ظ´
295·Öµ÷¼Á
ÒѾÓÐ0È˻ظ´
˹̹¸£´óѧÕÐÊÕÐÄѪ¹Ü·½Ïò²©Ê¿ºó£¡
ÒѾÓÐ0È˻ظ´
¡¾ÕÐÉúÆôÊ¡¿°ÄÃÅ´óѧÖлªÒ½Ò©Ñо¿Ôº¹ú¼ÒÖØµãʵÑéÊÒÕÐÊÕ˶ʿ²©Ê¿Ñо¿Éú
ÒѾÓÐ1È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
¼ÃÄÏ´óѧÁÖÐã¾ê½ÌÊÚÕÐÊÕ²ÄÁÏÀ಩ʿÉú
+1/90
רҵ¼¼Êõ¿ª·¢¼°µÚÈý·½¼ì²â
+1/87
Ìì½òÀí¹¤´óѧ¹ú¼Ò½ÜÇàÍõÌú¿ÎÌâ×éÕÐÊÕ2026Ä격ʿÑо¿Éú
+1/85
ÓÐûÓÐÔÚÏã¸ÛµÄ³æÓѰ¡
+1/79
ÏæÌ¶´óѧ¡°¹ý³ÌÇ¿»¯ÓëÂÌÉ«»¯¹¤¡±´´ÐÂÍŶӲ¹ÕÐ2026ÄêÇïÈëѧ²©Ê¿Éú
+1/35
ÄÏ¿ª´óѧÂÞ¾°É½½ÌÊÚ¿ÎÌâ×éÕÐÆ¸²©Ê¿ºó£¨¹â/µç´ß»¯¡¢¸ÆîÑ¿ó¹â·ü·½Ïò£©
+2/34
°Ä´óÀûÑÇÎ÷°Ä´óѧ£¨UWA£©ÕŽðÇ¿¿ÎÌâ×éÕÐÊÕÈ«½±²©Ê¿Éú£¨»¯¹¤ÐÂÄÜÔ´·½Ïò£©
+1/32
·ÄÖ¯¿ÆÑ§Ó빤³Ì¡¢²ÄÁÏ»¯¹¤·½ÏòÕÐÊÕÑо¿Éú
+1/28
±¨ÃûͨµÀ¿ªÆôÀ²£¡Õã½ÖÐÒ½Ò©´óѧ¸±Ð£³¤ÍŶÓÕÐÆ¸Ò©Ñ§/ÉúÎïÐÅϢѧµÈ·½Ïò¸ßУ½Ìʦ7Ãû(µØµ
+1/27
Ïã¸Û´óѧDavid Srolovitz½ÌÊÚ¿ÎÌâ×éÕÐÆ¸¡¸Ïã½Ñ§Õß¡¹²©Ê¿ºó
+1/7
Î人·ÄÖ¯´óѧ½ÜÇàÍŶÓÕÐÑо¿Éú£¨²ÄÁÏ£¬»¯Ñ§£¬¸ß·Ö×Ó£¬»¯¹¤£©
+1/7
»ªÖпƼ¼´óѧ¹ÜÀíѧԺÕÐÆ¸Éç»áÓù¤£¨¿ÆÑÐÖúÀí£©1Ãû
+1/6
211/˫һÁ÷ʯºÓ×Ó´óѧ»¯Ñ§»¯¹¤Ñ§Ôº--µç´ß»¯£¬CO2ת»¯
+1/6
ÉϺ£µÚ¶þ¹¤Òµ´óѧ-Öì´óº£¿ÎÌâ×éÕÐÉú£¨¹ýÏß¾ÍÄܵ÷¼Á£©
+1/5
ÄÏ·½¿Æ¼¼´óѧ»ù´¡ÃâÒßÓë΢ÉúÎïѧϵÕÐÆ¸¿ÆÑÐÖúÀí1-2Ãû£¬´ÓÊÂ΢ÉúÎïÓëÃâÒßѧ·½ÏòÑо¿
+1/5
ÕÐÊÕ»¯¹¤Óë²ÄÁÏѧ¿ÆµãÑо¿Éú
+1/5
¸£½¨Ê¦·¶´óѧ»·¾³Î¢ÉúÎï¼¼Êõ¿ÎÌâ×é½ÓÊÜ2026¼¶Ë¶Ê¿µ÷¼Á
+1/2
ÉϺ£½»Í¨´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÅÖÇÌοÎÌâ×é³ÏƸ²©Ê¿ºó
+1/2
îÙÄ¤ÆÆ¾Ö£¬¾ÛÁ¦ÇâÄÜ¡ª¡ªÔÚ¼¼ÊõÉî¸ûÖаÑÎÕлúÓö
+1/2
±±¾©¸ßУ¸±Ð£³¤ÍŶÓÕÐÊÕ»úеÀ࣬»·¾³Ààѧ˶ºÍר˶
+1/1
5Â¥2016-03-07 11:35:10
¼òµ¥»Ø¸´
SilenceGoo2Â¥
2016-03-01 10:36
»Ø¸´
linglingchen(½ð±Ò+1): лл²ÎÓë
tzynew3Â¥
2016-03-01 13:48
»Ø¸´
linglingchen(½ð±Ò+1): лл²ÎÓë
±¦±´¹Ô¹Ô¿ìÀ´4Â¥
2016-03-01 14:29
»Ø¸´
linglingchen(½ð±Ò+1): лл²ÎÓë
×£¸£













»Ø¸´´ËÂ¥